Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis

This publication has 16 references indexed in Scilit:

• A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with Novastan and TPA (MINT) study
  Journal of the American College of Cardiology, 1999
• Comparative Studies of an Orally-active Factor Xa Inhibitor, YM-60828, with other Antithrombotic Agents in a Rat Model of Arterial Thrombosis
  Thrombosis and Haemostasis, 1998
• Antithrombotic effects of YM‐60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time
  British Journal of Pharmacology, 1998
• Antithrombotic and Hemorrhagic Effects of DX-9065a, a Direct and Selective Factor Xa Inhibitor: Comparison with a Direct Thrombin Inhibitor and Antithrombin Ill-Dependent Anticoagulants
  Thrombosis and Haemostasis, 1997
• Direct thrombin inhibitors in cardiovascular disease
  Coronary Artery Disease, 1997
• Hirudin in Acute Myocardial Infarction
  Circulation, 1996
• Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris
  Journal of the American College of Cardiology, 1993
• Low molecular weight heparin
  Blood, 1992
• Argatroban, A Selective, Potent Thrombin Inhibitor
  Cardiovascular Drug Reviews, 1991
• Rat model of arterial thrombosis induced by ferric chloride
  Thrombosis Research, 1990